Commonwealth Equity Services’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $302K | Sell |
59,621
-6,722
| -10% | -$34K | ﹤0.01% | 3574 |
|
|
2025
Q1 | $351K | Buy |
66,343
+12,024
| +22% | +$63.6K | ﹤0.01% | 3350 |
|
|
2024
Q4 | $367K | Sell |
54,319
-4,582
| -8% | -$31K | ﹤0.01% | 3231 |
|
|
2024
Q3 | $388K | Buy |
58,901
+14,660
| +33% | +$96.6K | ﹤0.01% | 3115 |
|
|
2024
Q2 | $332K | Buy |
44,241
+9,058
| +26% | +$68K | ﹤0.01% | 3212 |
|
|
2024
Q1 | $351K | Buy |
35,183
+13,183
| +60% | +$132K | ﹤0.01% | 3131 |
|
|
2023
Q4 | $217K | Buy |
22,000
+815
| +4% | +$8.04K | ﹤0.01% | 3445 |
|
|
2023
Q3 | $162K | Buy |
21,185
+5,550
| +35% | +$42.4K | ﹤0.01% | 3460 |
|
|
2023
Q2 | $117K | Buy |
+15,635
| New | +$117K | ﹤0.01% | 3547 |
|